Table 3.
Selection of possible lncRNA targets for future lung cancer therapy.
| lncRNA | Expression in LC | Involved Process | Possible Benefit | Reference |
|---|---|---|---|---|
| HOTAIR H19 SNHG1 |
High | Biomarker in Sputum | Early and non-invasive diagnosis | [160] |
| LOC146880 Xist |
High | Biomarker in Serum | Early diagnosis | [161] |
| H19 | High | Proliferation, Cisplatin resistance |
Inhibition of tumor growth, improvement of chemotherapy |
[162,163] |
| HOTAIR | High | Migration, Cisplatin resistance |
Reduced metastasis, improvement of chemotherapy |
[164] |
| BANCR | Low | Migration, radioresistance |
Reduced metastasis, improvement of radiotherapy |
[165] |
| ANRIL | High | Proliferation, radioresistance |
Reduced tumor growth, improvement of radiotherapy |
[166] |